DADC
AMPE

D.A. Davidson & Co’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

D.A. Davidson & Co’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-17
Closed -$41K – 2200
2014
Q2 		$41K Hold
17
– – ﹤0.01% 1473
2014
Q1 		$31K Buy
+17
New +$40.2K ﹤0.01% 1538

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

D.A. Davidson & Co's AMPE Position: Q3 2014 in Review

D.A. Davidson & Co sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2014, closing a stake of 17 shares — an estimated $41K sold.

D.A. Davidson & Co first reported a position in AMPE in Q1 2014 and held it in 2 quarters. The position peaked at $41K in Q2 2014. 80 funds tracked by Wall St. Rank hold AMPE as of Q3 2014.

  • D.A. Davidson & Co reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2014 after selling out during the quarter.
  • D.A. Davidson & Co sold 17 Ampio Pharmaceuticals Inc. shares in Q3 2014, an estimated $41K.
  • D.A. Davidson & Co first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 2 quarters.
  • D.A. Davidson & Co's Ampio Pharmaceuticals Inc. position peaked at $41K in Q2 2014.
  • 80 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2014.

Based on D.A. Davidson & Co's 13F filing for Q3 2014, filed 12 Nov 2014.